Brain Regions and Functional Neuronal Network Characteristics of Dexmedetomidine Analgesia

PHASE4CompletedINTERVENTIONAL
Enrollment

28

Participants

Timeline

Start Date

January 15, 2024

Primary Completion Date

December 15, 2024

Study Completion Date

December 20, 2024

Conditions
EpilepsyRadiofrequency AblationIntracranial Surgery
Interventions
DRUG

Dexmedetomidine Injectable Solution

continuous pump of 1.5ug / kg / h Dexmedetomidine 15min before anesthesia induction, continuous infusion for 30min after anesthesia induction, and then nuclear magnetic scanning was started.

DRUG

Sodium Chloride 0.9% Inj

the equivalent Sodium Chloride 0.9% Inj was continuously pumped before anesthesia induction, induced by opioids for 15min, and intraoperative fMRI scanning was started after continuous infusion for 30min.

Trial Locations (1)

100053

Xuanwu hospital, Beijing

All Listed Sponsors
lead

China International Neuroscience Institution

OTHER

NCT05500703 - Brain Regions and Functional Neuronal Network Characteristics of Dexmedetomidine Analgesia | Biotech Hunter | Biotech Hunter